Filing Details

Accession Number:
0001181431-12-017353
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-14 18:14:21
Reporting Period:
2012-03-12
Filing Date:
2012-03-14
Accepted Time:
2012-03-14 18:14:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1162194 Fluidigm Corp FLDM Laboratory Analytical Instruments (3826) 770513190
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1435931 Maxwell William Smith Fluidigm Corporation
7000 Shoreline Court Suite 100
South San Francisco CA 94080
Evp, Legal Affairs & Gc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-12 3,000 $1.82 52,545 No 4 M Direct
Common Stock Disposition 2012-03-12 3,000 $15.72 49,545 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Employee Stock Option (Right to Buy) Disposition 2012-03-12 3,000 $0.00 3,000 $1.82
Common Employee Stock Option (Right to Buy) Acquisiton 2009-11-17 5,780 $0.00 5,780 $4.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,412 2013-07-15 No 4 M Direct
5,780 2019-11-17 No 4 A Direct
Footnotes
  1. The sales reported by Mr. Smith were effected pursuant to a Rule 10b5-1 trading plan adopted on September 6, 2011.
  2. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $15.61 to $15.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein
  3. The Option fully vested on April 1, 2007.
  4. The Option is not a new grant but is listed herein to correct the vesting schedule previously reported on a Form 3 filed by the reporting person on February 9, 2011. The filed Form 3 reported that 70% of the shares subject to the Option vested on December 31, 2009, 25% of the remaining 30% of the shares subject to the Option vested on April 1, 2010 and 1/48th of the remaining unvested shares subject to the Option shall vest each month thereafter. However, such Form 3 should have reported that 61% of the shares subject to the Option vested on December 31, 2009, 25% of the remaining 39% of the shares subject to the Option vested on April 1, 2010 and 1/48th of the remaining 39% of the shares subject to the Option shall vest each month thereafter such that all shares subject to the Option shall be fully vested on April 1, 2013.
  5. Reflects a 1-for-1.73 reverse stock split of the Issuer's outstanding shares effected February 3, 2011.